We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$6.09B
AUM Growth
+$393M
Cap. Flow
-$95.1M
Cap. Flow %
-1.56%
Top 10 Hldgs %
33.43%
Holding
956
New
52
Increased
378
Reduced
294
Closed
42

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$10.7M
2
QGENF
QIAGEN NV
QGENF
+$8.34M
3
CSCO icon
Cisco
CSCO
+$8.11M
4
FRC
First Republic Bank
FRC
+$7.27M
5
PSX icon
Phillips 66
PSX
+$6.75M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$39M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.6M
3
TGT icon
Target
TGT
+$10.9M
4
GE icon
GE Aerospace
GE
+$10.3M
5
PNC icon
PNC Financial Services
PNC
+$8.52M

Sector Composition

Rank Sector Weight
1 Financials 29.83%
2 Healthcare 16%
3 Technology 10.83%
4 Communication Services 9.48%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
526
Teva Pharmaceuticals
TEVA
$41.2B
$584K 0.01%
14,562
-44,654
-75% -$1.76M
HOLX
527
DELISTED
Hologic
HOLX
$583K 0.01%
26,078
-11,300
-30% -$249K
AUXL
528
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$581K 0.01%
28,100
+600
+2% +$11.3K
TLM
529
DELISTED
TALISMAN ENERGY INC
TLM
$565K 0.01%
48,600
-10,600
-18% -$127K
NWL icon
530
Newell Brands
NWL
$2.56B
$555K 0.01%
17,228
+400
+2% +$11.9K
SM icon
531
SM Energy
SM
$6.87B
$555K 0.01%
6,669
+5,080
+320% +$433K
CLB icon
532
Core Laboratories
CLB
$521M
$553K 0.01%
2,900
+2,600
+867% +$484K
MNTA
533
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$536K 0.01%
29,800
+800
+3% +$13.4K
LXRX icon
534
Lexicon Pharmaceuticals
LXRX
$1.1B
$529K 0.01%
41,771
+857
+2% +$13.6K
DYAX
535
DELISTED
DYAX CORPORATION
DYAX
$528K 0.01%
68,900
+8,000
+13% +$60.8K
APO icon
536
Apollo Global Management
APO
$73.4B
$526K 0.01%
16,972
-7,000
-29% -$217K
JBL icon
537
Jabil
JBL
$35.8B
$525K 0.01%
30,811
– –
SSNI
538
DELISTED
Silver Spring Networks, Inc.
SSNI
$525K 0.01%
25,000
+19,000
+317% +$364K
VVUS
539
DELISTED
Vivus Inc
VVUS
$524K 0.01%
5,720
+100
+2% +$9.66K
SLRC icon
540
SLR Investment Corp
SLRC
$715M
$520K 0.01%
23,100
+12,400
+116% +$280K
ESV
541
DELISTED
Ensco Rowan plc
ESV
$517K 0.01%
2,284
– –
WX
542
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$513K 0.01%
+13,500
New +$426K
GHDX
543
DELISTED
Genomic Health, Inc.
GHDX
$509K 0.01%
17,400
+500
+3% +$15.9K
VRSN icon
544
VeriSign
VRSN
$26.6B
$506K 0.01%
8,535
– –
GTE icon
545
Gran Tierra Energy
GTE
$317M
$505K 0.01%
7,000
-500
-7% -$36.6K
IBN icon
546
ICICI Bank
IBN
$108B
$503K 0.01%
74,800
-16,500
-18% -$105K
TSM icon
547
TSMC
TSM
$2.18T
$502K 0.01%
28,559
+14,000
+96% +$249K
SE
548
DELISTED
Spectra Energy Corp Wi
SE
$494K 0.01%
14,116
– –
URI icon
549
United Rentals
URI
$72.4B
$493K 0.01%
6,400
+2,700
+73% +$181K
PSA icon
550
Public Storage
PSA
$61.3B
$489K 0.01%
3,233
-830
-20% -$133K
20 21
22
23 24

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q4 2013 Portfolio in Review

As of Q4 2013, DekaBank Deutsche Girozentrale held 956 positions worth $6.09B, up 6.9% from $5.69B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

DekaBank Deutsche Girozentrale's Q4 2013 filing shows 52 new, 378 increased, 294 reduced and 42 closed positions. Its largest new stake was Lazard: 264,565 shares worth $11.9M. The largest sale was Deutsche Bank, an estimated $39M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.

  • DekaBank Deutsche Girozentrale's largest Q4 2013 buy was Lazard: 264,565 shares worth $11.9M.
  • DekaBank Deutsche Girozentrale added most to QIAGEN NV in Q4 2013, an estimated $8.34M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2013 reduction was Deutsche Bank, cutting an estimated $39M.
  • DekaBank Deutsche Girozentrale fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $5.92M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 33% of its $6.09B portfolio in Q4 2013.
  • DekaBank Deutsche Girozentrale opened 52 new positions and closed 42 in Q4 2013.
  • DekaBank Deutsche Girozentrale's portfolio value rose 6.9% quarter-over-quarter to $6.09B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2013, filed 11 Feb 2014.